Are we missing tracks while prescribing proton pump inhibitors? - An opinion from clinicians cross sectional hospital based questionnaire study
Journal Title: IP International Journal of Comprehensive and Advanced Pharmacology - Year 2018, Vol 3, Issue 1
Abstract
Introduction Poton pump inhibitors are the main stage standard therapy for various gastrointestinal disorders such as upper gastrointestinal disorders GERD dyspepsia and peptic ulcer disease1 The availability of PPIs as an OTC drug and its over utilization in multiple disease backgrounds with or without symptoms has subjected patients to a potential risk such as parietal cell hypertrophy and hypergastrinemia leading to rebound acid secretion2 Studies have shown that between 40 to 65 of prescriptions for a PPI fail to have an appropriate indication3 Inapt stress ulcer prophylaxis SUP in hospital wards and in the clinical OPDs and failure to discontinue SUP prior to hospital discharge has amplified this risk4Aim To analyse the views opinion and judgement of every clinicians in our hospital regarding PPI prescription and factors they consider while prescribing and their views to decrease misuse of the sameMaterials and Methods This is a crosssectional opinion deriving hospital based questionnaire study where mostly physicians of all specialities were interviewed with a prestructured questionnaire containing 14 questionsResults 93 respondents of multispeciality background had variety of opinion about the practice of the PPIs in our hospital 247 of them treat 3140 patients per month on average with genuine gastrointestinal symptoms which mandate the use of proton pump inhibitors evidently 50 of the practitioners told they will prescribe for patient satisfaction and patients request for gastric tablets 467 of the practitioners didnrsquot think of deprescribing PPIs in asymptomatic patients Nearly 70 of them were either not sure or had any idea about the deprescribing PPI useKeywords Proton pump inhibitors Prescription practice Deprescribing guidelines Long term effects
Authors and Affiliations
Shashikiran D. , Padmaja Udaykumar
Keywords
Related Articles
- EP ID EP481708
- DOI 10.18231/2456-9542.2018.0008
- Views 115
- Downloads 0
Application of quality by design paradigm in the design of muco-adhesive extended release film for oral ulcer
The present study deals with the formulation of mucoadhesive bilayered buccal film of lidocaine hydrochloride and benzydamine hydrochloride for treatment of oral ulcers aphthous stomatitis EudragitRLPO and Ethyl cellulos...
Plumbagin as a mutli-target drug in treatment of cancer: A review
Cancer is the fastest growing disease and leading cause of death in the world. Several drugs are available for the treatment of cancer with their merits and demerits, but not a single molecule is available which claims t...
A retrospective study on prescription pattern of drugs used in myocardial infarction in a South Indian Tertiary Care Hospital
Introduction Angina pectoris the primary symptom of ischemic heart disease is caused by transient episodes of myocardial ischemia that are due to imbalance in the myocardial oxygen supplydemand relationship Various drugs...
Are we missing tracks while prescribing proton pump inhibitors? - An opinion from clinicians cross sectional hospital based questionnaire study
Introduction Poton pump inhibitors are the main stage standard therapy for various gastrointestinal disorders such as upper gastrointestinal disorders GERD dyspepsia and peptic ulcer disease1 The availability of PPIs as...
Adherence to medication in patients suffering from hypertension: A cross sectional study
Introduction Hypertension is a global health challenge and responsible for about 128 percent of the total of all global deaths due to cardiovascular diseases The prevention of cardiovascular disease requires long term ad...